Table 1.
General data of patients with AAV*.
Fig 1.
Serum levels of NETs in AAV patients in active stage and remission.
A. Quantification of cell free DNA using Quant-iT PicoGreen assay in serum samples from healthy donors (n = 22), individuals with AAV in remission (n = 62) and with active disease (n = 34). B. Quantification of NETs in the serum samples by MPO-DNA complex ELISA. The mean optical density as measured by capture ELISA.
Fig 2.
Serum levels of NETs in 20 AAV patients with sequential serum samples.
A. Serum levels of cell free DNA. B. Serum levels of MPO-DNA complexes.
Fig 3.
Renal NETs level of AAV patients and healthy control.
Fig 4.
Circulating DNase I concentration in AAV patients.